MARKET

PAVM

PAVM

Pavmed
NASDAQ
1.870
-0.010
-0.53%
After Hours: 1.990 +0.12 +6.42% 16:04 04/23 EDT
OPEN
1.870
PREV CLOSE
1.880
HIGH
1.930
LOW
1.830
VOLUME
27.43K
TURNOVER
0
52 WEEK HIGH
9.00
52 WEEK LOW
1.600
MARKET CAP
17.15M
P/E (TTM)
-0.2041
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PAVM last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at PAVM last week (0408-0412)?
Weekly Report · 04/15 11:14
Buy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product Commercialization
TipRanks · 04/15 09:16
PAVMED INC <PAVM.O>: ASCENDIANT CAPITAL MARKETS CUTS TARGET PRICE TO $26 FROM $30
Reuters · 04/15 03:04
Weekly Report: what happened at PAVM last week (0401-0405)?
Weekly Report · 04/08 11:20
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Shares of Doma Holdings Inc. Rose sharply in today’s pre-market trading. The company entered a merger transaction with TRG to go private at $6.29 per share in cash. Vast Renewables Limited shares rose 213.9% to $9.70 after jumping 39% on Thursday.
Benzinga · 04/01 12:08
Weekly Report: what happened at PAVM last week (0325-0329)?
Weekly Report · 04/01 11:17
12 Health Care Stocks Moving In Friday's Intraday Session
Avalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The company's market cap stands at $510.4 million. Nexalin Technology shares moved upwards by 83.33% and Biodexa Pharmaceuticals stock increased by 81.6%. Losers include Tonix Pharmaceuticals and Kodiak Sciences.
Benzinga · 03/29 16:30
More
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.

Webull offers PAVmed Inc stock information, including NASDAQ: PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.